Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality.

Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Garre-Olmo J.

Am J Geriatr Psychiatry. 2013 Nov;21(11):1135-43. doi: 10.1016/j.jagp.2013.01.051. Epub 2013 Feb 6.

PMID:
23567368
2.

Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors.

Vilalta-Franch J, Calvó-Perxas L, Garre-Olmo J, Turró-Garriga O, López-Pousa S.

J Alzheimers Dis. 2013;33(2):535-43. doi: 10.3233/JAD-2012-120913.

PMID:
23001707
3.

Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia.

Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ.

J Am Geriatr Soc. 1993 Jan;41(1):31-7.

PMID:
8418119
4.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
5.

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.

Lopez OL, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST.

Neurology. 1997 Jun;48(6):1521-5.

PMID:
9191759
6.

Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes.

Wilkosz PA, Miyahara S, Lopez OL, Dekosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2006 Apr;14(4):352-60.

PMID:
16582044
7.

Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.

Koppel J, Goldberg TE, Gordon ML, Huey E, Davies P, Keehlisen L, Huet S, Christen E, Greenwald BS.

Am J Geriatr Psychiatry. 2012 Nov;20(11):994-1000. doi: 10.1097/JGP.0b013e3182358921.

PMID:
22048323
8.

Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.

Ryu SH, Katona C, Rive B, Livingston G.

Am J Geriatr Psychiatry. 2005 Nov;13(11):976-83.

PMID:
16286441
9.

Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG.

Int J Geriatr Psychiatry. 2000 Feb;15(2):99-107.

PMID:
10679840
10.

Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.

Gormley N, Rizwan MR.

Int J Geriatr Psychiatry. 1998 Jun;13(6):410-4.

PMID:
9658277
11.

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV.

Neurology. 2000 May 23;54(10):1965-71.

PMID:
10822438
12.

Evolution of depressive symptoms in Alzheimer disease: one-year follow-up.

Garre-Olmo J, López-Pousa S, Vilalta-Franch J, Turon-Estrada A, Hernàndez-Ferràndiz M, Lozano-Gallego M, Fajardo-Tibau C, Puig-Vidal O, Morante-Muñoz V, Cruz-Reina MM.

Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):77-85.

PMID:
12794384
13.

Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study.

Sawada H, Oeda T, Yamamoto K, Umemura A, Tomita S, Hayashi R, Kohsaka M, Kawamura T.

BMC Neurol. 2013 Oct 12;13:145. doi: 10.1186/1471-2377-13-145.

14.

Psychosis of Alzheimer's disease: clinical characteristics and history.

Schneider LS, Dagerman KS.

J Psychiatr Res. 2004 Jan;38(1):105-11. Review.

PMID:
14690773
15.
16.

Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.

Turró-Garriga O, Garre-Olmo J, Calvó-Perxas L, Reñé-Ramírez R, Gascón-Bayarri J, Conde-Sala JL.

J Alzheimers Dis. 2016;51(2):357-66. doi: 10.3233/JAD-150706.

PMID:
26890611
17.

Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.

Sourdet S, van Kan GA, Soto ME, Houles M, Cantet C, Nourhashemi F, Vellas B, Pahor M, Rolland Y.

J Am Med Dir Assoc. 2012 May;13(4):407.e1-6. doi: 10.1016/j.jamda.2011.11.003. Epub 2012 Jan 9.

PMID:
22227074
18.

Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.

van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT, Verhey FR.

Dement Geriatr Cogn Disord. 2012;34(5-6):319-27. doi: 10.1159/000342824. Epub 2012 Dec 3.

PMID:
23208452
19.

The epidemiology of psychosis in dementia.

Leroi I, Voulgari A, Breitner JC, Lyketsos CG.

Am J Geriatr Psychiatry. 2003 Jan-Feb;11(1):83-91.

PMID:
12527543
20.

Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.

Palmer K, Lupo F, Perri R, Salamone G, Fadda L, Caltagirone C, Musicco M, Cravello L.

J Alzheimers Dis. 2011;24(1):35-45. doi: 10.3233/JAD-2010-101836.

PMID:
21157019

Supplemental Content

Support Center